MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the first and only non-incisional permanent birth control method available, reports that more than 20 new, independent studies show that the Essure® permanent birth control procedure has a very high success rate, a short physician learning curve and high patient satisfaction. Collectively, the data suggest that the Essure procedure can easily be done in a physician’s office and does not require general anesthesia.
